Madrigal Pharmaceuticals (MDGL) Revenue (2010 - 2026)
Madrigal Pharmaceuticals' Revenue came in at $364.25 million for Q2 2026, up 71.2% from $212.8 million a year earlier and up 17.0% from the prior quarter.
Powered by 
Analysis
Madrigal Pharmaceuticals (MDGL) Revenue (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Madrigal Pharmaceuticals reported Revenue of $1.28 billion, up 149.0% year-over-year; for FY2025, it was $958.4 million, up 432.1% from FY2024.
- Going back by year, Revenue was $180.13 million in FY2024.
- The Q2 2026 figure represents the highest quarterly Revenue in data going back to Q2 2010.
- Year-over-year, Revenue has increased for four consecutive quarters, with growth averaging 192.7% over the last four quarters.
- Business Quant data shows MDGL's Revenue at $311.34 million (Q1 2026), $321.08 million (Q4 2025) and $287.27 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Madrigal Pharmaceuticals | 13.33 Bn | 9.58 Bn | - | 364.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 364.25 Mn |
| Mar 31, 2026 | 311.34 Mn |
| Dec 31, 2025 | 321.08 Mn |
| Sep 30, 2025 | 287.27 Mn |
| Jun 30, 2025 | 212.80 Mn |
| Mar 31, 2025 | 137.25 Mn |
| Dec 31, 2024 | 103.32 Mn |
| Sep 30, 2024 | 62.18 Mn |
| Jun 30, 2024 | 14.64 Mn |
| Sep 30, 2016 | 41,778.00 |
| Jun 30, 2016 | 19,000.00 |
| Mar 31, 2016 | -77,000.00 |
| Dec 31, 2015 | -156,000.00 |
| Sep 30, 2015 | -919,805.00 |
| Jun 30, 2015 | -296,000.00 |
| Mar 31, 2015 | -375,000.00 |
| Dec 31, 2014 | -458,000.00 |
| Sep 30, 2014 | -517,000.00 |
| Jun 30, 2014 | -585,000.00 |
| Mar 31, 2014 | -650,000.00 |
API Access
Madrigal Pharmaceuticals Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=MDGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "MDGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=MDGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();